EVP Brian Travis Buys 1750 Eastman Chemical Shares at $68.34/Share on 2025-08-27.
ByAinvest
Friday, Aug 29, 2025 4:09 pm ET1min read
EMN--
The purchase of 1750 shares by Smith brings his direct beneficial ownership to 16,732 shares. Additionally, Smith received 2,200 phantom stock units under the company's Executive Deferred Compensation Plan, valued at $68.18 per share. These phantom units are subject to plan terms, including limited acceleration and withdrawal provisions, and will be paid in cash after Smith's employment termination [2].
Eastman Chemical has faced challenges in recent months, with a decline in revenue growth and below-average profitability metrics. However, the insider purchases may suggest optimism among executives regarding the company's future prospects. Investors should consider this information as part of their overall analysis, but not as a primary determinant for investment decisions [1].
References:
[1] https://www.benzinga.com/insights/news/25/08/47416263/evp-of-eastman-chemical-makes-252k-buy
[2] https://www.stocktitan.net/sec-filings/EMN/form-4-eastman-chemical-company-insider-trading-activity-82ef0059e79b.html
Eastman Chemical Company [EMN] has disclosed that EVP, AFP, Mfg., WWEC & HSE Brian Travis Smith has purchased 1750 shares at a price of $68.34 per share on August 27, 2025.
Eastman Chemical Company [EMN] has disclosed that EVP, AFP, Mfg., WWEC & HSE Brian Travis Smith has purchased 1750 shares at a price of $68.34 per share on August 27, 2025. The transaction, reported in a Form 4 filing with the U.S. Securities and Exchange Commission, signifies a significant insider buy. This follows a trend of insider purchases at Eastman Chemical, indicating a positive outlook on the company's stock performance [1].The purchase of 1750 shares by Smith brings his direct beneficial ownership to 16,732 shares. Additionally, Smith received 2,200 phantom stock units under the company's Executive Deferred Compensation Plan, valued at $68.18 per share. These phantom units are subject to plan terms, including limited acceleration and withdrawal provisions, and will be paid in cash after Smith's employment termination [2].
Eastman Chemical has faced challenges in recent months, with a decline in revenue growth and below-average profitability metrics. However, the insider purchases may suggest optimism among executives regarding the company's future prospects. Investors should consider this information as part of their overall analysis, but not as a primary determinant for investment decisions [1].
References:
[1] https://www.benzinga.com/insights/news/25/08/47416263/evp-of-eastman-chemical-makes-252k-buy
[2] https://www.stocktitan.net/sec-filings/EMN/form-4-eastman-chemical-company-insider-trading-activity-82ef0059e79b.html

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet